Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...

Investors chasing artificial intelligence returns have crowded into the obvious chip leaders, but the biggest percentage ...

The dividend yield on the S&P 500 is currently around 1.2%, which is near its all-time low. As a result, it's getting harder ...

Backed by balance sheet clean-ups, execution revivals and sectoral tailwinds, these are the “power performers” that could ...

Hong Kong and India lead Asia's fundraising surge, with record IPOs and robust market activity amid rising investor ...

If earnings stabilise and domestic liquidity stays healthy, 2026 still has room to surprise on the upside for the market, ...

AbbVie (ABBV) just caught a fresh tailwind after HSBC bumped the stock to a Buy, a move that comes on top of strong quarterly ...

Overall, among the developments he will be watching in 2026 include: "a BDC's ability to source attractive investments, ...

No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading ...